Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11248218 Botulinum neurotoxin and its derivatives

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 23 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 23 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=1124821800
Edits on 29 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 29 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 28 Apr, 2023
Edits on 24 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 24 Apr, 2023
Edits on 5 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 5 Apr, 2023
Edits on 28 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 28 Sep, 2022
Edits on 27 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 27 Sep, 2022
Edits on 25 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
Edits on 23 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 23 Sep, 2022
Edits on 6 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 6 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=11248218
Edits on 16 Feb, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 16 Feb, 2022
Edits made to:
Infobox (+13 properties)
‌

 US Patent 11248218 Botulinum neurotoxin and its derivatives

Infobox
Is a
Patent
Patent
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
11248218
Date of patent
February 15, 2022
Patent application number
16315698
Date Filed
July 7, 2017
Patent citations
‌
US Patent 10190110 Engineered botulinum neurotoxin
‌
US Patent 10266816 Carrier for targeting nerve cells
‌
US Patent 10501731 Degradable clostridial toxins
‌
US Patent 10647750 Cationic neurotoxins
‌
US Patent 10648045 Chimeric polypeptides
‌
US Patent 10704035 Compositions and methods for treatment of pain
Patent primary examiner
‌
Nita M. Minnifield

Find more entities like US Patent 11248218 Botulinum neurotoxin and its derivatives

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.